ACE and Alzheimer disease: Given the potential links of these protein levels with the diseases discussed above, we hypothesized that levels of ACE1 enzyme and APO proteins, as potential biomarkers may be involved in the developments of AD, CVD and EMD via abnormal cholesterol efflux, cholesterol transport, immune system imbalance and/or in endothelial dysfunction.